Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Metastatic and Recurrent Cervical Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer. Accessed 23 September 2023.
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer. Accessed September 23, 2023.
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer
Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Metastatic and Recurrent Cervical Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 September 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer
ID - 431950
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -